Immune Memory
Immune Memory
批准号:
8468620
负责人:
Rafi Ahmed
金额:
$40.33万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
未结题
起止时间:
2003-09-30 至
关键词:
3&apos Untranslated RegionsAcuteAntiviral ResponseAttenuated Live Virus VaccineAttenuated VaccinesB-LymphocytesBenchmarkingCD8B1 geneCell CycleCell Differentiation processCell ProliferationCellsChronicDataDiseaseEffector CellEmployee StrikesEpigenetic ProcessFamilyFundingGenerationsGenesGenomicsGoalsHomingHumanHumoral ImmunitiesImmuneImmune responseImmunityImmunizationImmunologic MemoryInfectionKnowledgeLifeMaintenanceMemoryMethylationMicroarray AnalysisModelingMolecularMolecular ProfilingMonitorPathway interactionsPlayPopulationPositioning AttributeRNA InterferenceResolutionRoleSex Combs on MidlegShapesSmallpoxT cell differentiationT cell responseT memory cellT-LymphocyteTestingVaccinesVirus DiseasesYellow fever virusagedbasehuman monoclonal antibodiesimprovedin vivoinfluenza virus vaccinelongitudinal analysisnovel vaccinesresearch studyresponsetechnology developmenttranscription factorvaccine-induced immunity
中文摘要
我们的目标是了解一种成功的疫苗如何诱导长期的免疫记忆和保护
人类的免疫力。为了实现这一目标,我们已经开始了详细的细胞和分子表征
关于黄热病病毒(YFV-17D)疫苗诱导的人类免疫反应。这是我们最大的
有效的疫苗,并诱导持续数十年的长期免疫。另外,由于YFV-17D是一种活的
减毒疫苗和大多数美国人都不会接触YFV-,这提供了一种独特的
有机会分析人类在初次感染过程中的抗病毒反应,然后
监测感染消退后免疫记忆的产生和维持。其中一个
了解一种成功的疫苗如何诱导长期保护性免疫的潜在好处是
这些知识可以用于改进其他效果较差的疫苗,更重要的是,可以用来开发
针对新出现的疾病的新疫苗。在上一个资金周期中,我们取得了很大的进展
人类记忆T和B细胞对YFV和YFV免疫应答的研究进展
接种天花和流感疫苗。在本次续费申请中,我们将重点研究
CDS T细胞,并研究调节人类效应和记忆CDS T细胞的机制
差异化。为了实现我们的目标,我们提出了以下具体目标:1)识别转录
调节幼稚的因素对CDS T//分化的影响。2)分析人体在体内的周转
检测YFV特异性CDS T细胞的归巢潜能。3)定义基因组和表观遗传学
人类记忆CDS T细胞分化过程中发生的变化。这些研究将提供第一个
人类CDS T细胞分化后发生的转录变化的观点,并将提供
独特的标记,能够识别、分离和鉴定分化的细胞亚群。
T细胞应答过程中表观DNA甲基化标记的检测
至于CD8T细胞对急性和慢性病毒感染的反应将提供潜在的
记忆CDS T细胞分化如何被全局调控的机械论观点。
英文摘要
Our goal is to understand how a successful vaccine induces long-term immunological memory and protective
immunity in humans. To achieve this goal we have initiated a detailed cellular and molecular characterization
of human immune responses induced by the yellow fever virus (YFV-17D) vaccine. This is one of our most
efficacious vaccines and induces long-term immunity that lasts for decades. Also, since YFV-17D is a live
attenuated vaccine and most of the U.S. population is not exposed to YFV-, this provides a unique
opportunity to analyze antiviral responses in humans during the course of a primary infection and then to
monitor the generation and maintenance of immune memory after resolution of the infection. One of the
potential benefits of understanding how a successful vaccine induces long-term protective immunity is that
this knowledge can be applied to improving other less effective vaccines and, more importantly, to develop
new vaccines against emerging diseases. During the previous cycle of funding we have made substantial
progress in characterizing human memory T and B cell responses not only to YFV but also after
immunization with small pox and influenza vaccines. In this renewal application we will focus our studies on
CDS T cells and examine the mechanisms that regulate human effector and memory CDS T cell
differentiation. The following specific aims are proposed to achieve our goals: 1) To identify transcription
factors that regulate naive to effector CDS Tee// differentiation. 2) To analyze the in vivo turnover of human
YFV specific CDS T cells and to examine their homing potential. 3) To define the genomic and epigenetic
changes that occur during human memory CDS T cell differentiation.These studies will will provide the first
view of the transcriptional changes that occur following CDS T cell differentiation in humans and will provide
unique markers that will enable identification, isolation, and characterization of the differentiated cell subsets.
Examination of the epigenetic DMA methylation marks during the progression of the T cell response, as well
as between CD8 T cells responding to acute versus chronic viral infections will provide a potential
mechanistic view of how memory CDS T cell differentiation is globally regulated.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunological Memory to Covid-19
-
批准号:10632659
-
项目类别:
-
资助金额:$210.0万
-
财政年份:2022
-
负责人:Rafi Ahmed
-
依托单位:
System Biological Analyses of Innate and Adaptive Responses to Vaccination
-
批准号:10345981
-
项目类别:
-
资助金额:$46.64万
-
财政年份:2021
-
负责人:Rafi Ahmed
-
依托单位:
System Biological Analyses of Innate and Adaptive Responses to Vaccination
-
批准号:10375723
-
项目类别:
-
资助金额:$46.77万
-
财政年份:2021
-
负责人:Rafi Ahmed
-
依托单位:
System Biological Analyses of Adaptive Responses to vaccination
-
批准号:10201503
-
项目类别:
-
资助金额:$230.01万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
Exploiting the Mechanobiology of PD-1 for Cancer Immunotherapy
-
批准号:10174887
-
项目类别:
-
资助金额:$64.02万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
System Biological Analyses of Innate and Adaptive Responses to Vaccination
-
批准号:10056675
-
项目类别:
-
资助金额:$240.49万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
Exploiting the Mechanobiology of PD-1 for Cancer Immunotherapy
-
批准号:10408747
-
项目类别:
-
资助金额:$62.39万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
Core-002
-
批准号:10394367
-
项目类别:
-
资助金额:$26.53万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
Exploiting the Mechanobiology of PD-1 for Cancer Immunotherapy
-
批准号:10524207
-
项目类别:
-
资助金额:$7.9万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
Project 1: Immune Memory
-
批准号:10394365
-
项目类别:
-
资助金额:$251.68万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
System Biological Analyses of Innate and Adaptive Responses to Vaccination
-
批准号:10201491
-
项目类别:
-
资助金额:$221.36万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
Exploiting the Mechanobiology of PD-1 for Cancer Immunotherapy
-
批准号:10634636
-
项目类别:
-
资助金额:$61.64万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
Vaccine Induced Immunity in the Young and Aged
-
批准号:10265788
-
项目类别:
-
资助金额:$278.21万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
Exploiting the Mechanobiology of PD-1 for Cancer Immunotherapy
-
批准号:10381102
-
项目类别:
-
资助金额:$7.6万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
Project 1: Immune Memory
-
批准号:10167989
-
项目类别:
-
资助金额:$219.36万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
Core-002
-
批准号:10618504
-
项目类别:
-
资助金额:$3.9万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
Exploiting the Mechanobiology of PD-1 for Cancer Immunotherapy
-
批准号:10737760
-
项目类别:
-
资助金额:$7.9万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
Project 1: Immune Memory
-
批准号:10618505
-
项目类别:
-
资助金额:$37.05万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
Bispecific molecules linking T cell receptor and tumor antigen for cancer immunotherapy
-
批准号:10747580
-
项目类别:
-
资助金额:$7.99万
-
财政年份:2020
-
负责人:Rafi Ahmed
-
依托单位:
Project 1: Evaluating stem-like T cells and improving efficacy of checkpoint inhibitors in NSCLC
-
批准号:10459440
-
项目类别:
-
资助金额:$53.73万
-
财政年份:2019
-
负责人:Rafi Ahmed
-
依托单位:
海外基金